AABB 2005: new products, techniques and automation on the agenda
This article was originally published in Clinica
Executive Summary
Tools for safer blood products, emerging technologies and automation were among the key themes at the annual AABB exhibition and meeting on October 14-18 2005, in Seattle, Washington, which attracted 3% more attendees (7,049), 17% of them hailing from outside the US. HBV NAT and bacterial contamination testing were major topics of discussion from a clinical issues standpoint, and there was much new product approval and launch news during what was an exciting show, writes Kerri Weinert and Carrie Cresenzi, of Boston Biomedical Consultants Inc